세계의 세포 및 유전자 치료 CDMO 시장 보고서(2025년)

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025

US $ 4,490 ￦ 6,339,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,163,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,987,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세포 및 유전자 치료 CDMO 시장 규모는 향후 몇 년 동안 연평균 27.8%의 성장률을 기록하며 2029년에는 185억 4,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 치료 용도 확대, 규제 진화, 투자 증가, 기술 혁신, 세계 협력 관계 등에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 개인 맞춤형 치료에 대한 수요 증가, 자동화 및 디지털화 발전, 제조 능력 확대, 새로운 전달 시스템의 출현, 지속가능성 및 환경 영향에 대한 관심 증가 등을 들 수 있습니다.

암 환자 증가는 세포 및 유전자 치료제 개발 및 제조 위탁생산(CDMO) 시장의 성장을 가속할 것으로 예측됩니다. CDMO는 인구 고령화, 생활습관 변화, 환경 노출, 검출 방법의 개선으로 인해 비정상적인 세포의 통제 불가능한 증식과 확산을 특징으로 하는 암이 점점 더 흔해지고 있으며, CDMO는 효과와 환자 예후를 개선하는 혁신적인 표적 치료제를 개발 및 제조함으로써 암 퇴치에 중요한 역할을 하고 있습니다. 중요한 역할을 하고 있습니다. 예를 들어, 영국에 기반을 둔 자선단체인 맥밀런 암 지원(Macmillan Cancer Support)에 따르면, 영국에서 암을 앓고 있는 사람의 수는 2022년 300만 명에서 2025년 350만 명, 2030년 400만 명, 2030년 530만 명으로 늘어날 것으로 예측됩니다. 그 결과, 암 환자 증가가 세포 및 유전자 치료 CDMO 시장의 성장을 견인하고 있습니다.

세포 및 유전자 치료 CDMO 시장의 주요 기업들은 세포 기반 제품 제조의 확장성, 효율성, 품질을 향상시키기 위해 PluriMatrix 기술과 같은 첨단 솔루션을 통합하여 포트폴리오를 확장하는 데 주력하고 있습니다. PluriMatrix 기술은 셀 기반 제품의 대규모 생산을 위해 설계된 독자적인 시스템입니다. 이 혁신적인 기술은 산업적 규모로 세포의 3차원 증식을 가능하게 하며, 자동화되고 완벽하게 제어되고 검증된 공정을 통해 높은 수율과 일관된 품질을 보장합니다. 예를 들어, 2024년 1월 이스라엘에 본사를 둔 생명공학 기업 Pluri는 CDMO로서 세포치료제 제조 서비스를 제공하는 새로운 사업부인 PluriCDMO를 도입했습니다. 이 새로운 사업부에는 47,000평방피트 규모의 GMP(의약품 제조관리 및 품질관리 기준) 준수 세포치료제 제조시설이 있습니다. Pluri의 새로운 사업부는 전임상 초기 단계부터 후기 임상, 상업화까지 엔드 투 엔드 서비스를 제공하며, 프로세스 및 분석 개발, 스케일업, 밸리데이션, 물류, 자동화, 규제 당국이 승인한 비교가능성 시험 등을 포함한다고 회사 측은 밝혔습니다. 회사는 발표했습니다. 이 회사는 최첨단 PluriMatrix 기술을 활용하여 첨단 세포치료제 제조 서비스를 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 세포 및 유전자 치료 CDMO PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 세포 및 유전자 치료 CDMO 시장 : 성장률 분석
• 세계의 세포 및 유전자 치료 CDMO 시장 실적 : 규모와 성장, 2019-2024
• 세계의 세포 및 유전자 치료 CDMO 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 세포 및 유전자 치료 CDMO 전체 시장(TAM)

제6장 시장 세분화

• 세계의 세포 및 유전자 치료 CDMO 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 유전자 치료
• 유전자 재조합 세포치료
• 세포치료
• 세계의 세포 및 유전자 치료 CDMO 시장 : Phase별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Phase 1
• Phase 2
• Phase 3
• Phase 4
• 세계의 세포 및 유전자 치료 CDMO 시장 : 적응증별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 종양학
• 감염증
• 신경질환
• 희귀질환
• 기타 적응증
• 세계의 세포 및 유전자 치료 CDMO 시장 : 유전자 치료 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 바이러스 벡터를 이용한 유전자 치료
• 비바이러스 유전자 치료
• 플라스미드 DNA를 이용한 유전자 치료
• 세계의 세포 및 유전자 치료 CDMO 시장 : 유전자 변형 세포치료 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• CAR-T 세포치료
• TCR-T 세포치료
• NK 세포치료
• 세계의 세포 및 유전자 치료 CDMO 시장 : 세포치료 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 줄기세포 치료
• 전구세포 치료
• 면역세포 치료

제7장 지역별/국가별 분석

• 세계의 세포 및 유전자 치료 CDMO 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 세포 및 유전자 치료 CDMO 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 세포 및 유전자 치료 CDMO 시장 : 경쟁 구도
• 세포 및 유전자 치료 CDMO 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • FUJIFILM Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• AGC Biologics
• Ajinomoto Co Inc.
• Lonza Group
• Catalent Inc.
• Charles River Laboratories International Inc.
• Sartorius Stedim Biotech
• Samsung Biologics Co Ltd
• WuXi Biologics
• Recipharm AB
• Almac Group Ltd
• KBI Biopharma
• Rentschler Biopharma
• Bio Elpida
• Oxford BioMedica Plc
• Avid Bioservices Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 세포 및 유전자 치료 CDMO 시장(2029년) : 새로운 기회를 제공하는 국가
• 세포 및 유전자 치료 CDMO 시장(2029년) : 새로운 기회를 제공하는 부문
• 세포 및 유전자 치료 CDMO 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

A cell and gene therapy contract development and manufacturing organization (CDMO) is a specialized company that supports the development, manufacturing, and commercialization of cell-based and gene therapy products. These organizations provide services tailored to the specific needs of companies developing advanced therapies, including biopharmaceutical companies, academic institutions, and government agencies. Cell and gene therapy CDMOs are crucial in speeding up the development and commercialization of advanced therapy products by offering specialized expertise, infrastructure, and services from early-stage development through to commercialization.

The primary product types offered by cell and gene therapy contract development and manufacturing organizations (CDMOs) include gene therapy, gene-modified cell therapy, and cell therapy. Gene therapy involves altering or manipulating the genes within a person's cells to treat or prevent disease. These therapies undergo various phases, including phase 1, phase 2, phase 3, and phase 4, and are developed for a range of indications such as oncology, infectious diseases, neurological disorders, rare diseases, and others.

The cell and gene therapy contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy contract development and manufacturing organization (CDMO) market statistics, including cell and gene therapy contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with a cell and gene therapy contract development and manufacturing organization (CDMO) market share, detailed cell and gene therapy contract development and manufacturing organization (CDMO) market segments, market trends, and opportunities, and any further data you may need to thrive in the cell and gene therapy contract development and manufacturing organization (CDMO) industry. This cell and gene therapy contract development and manufacturing organization (CDMO) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell and gene therapy contract development and manufacturing organization (CDMO) market size has grown exponentially in recent years. It will grow from $5.41 billion in 2024 to $6.94 billion in 2025 at a compound annual growth rate (CAGR) of 28.2%. The growth in the historic period can be attributed to increased technological advancements, favorable regulatory frameworks, increased investment, high prevalence of genetic disorders, and an increased number of strategic partnerships.

The cell and gene therapy contract development and manufacturing organization (CDMO) market size is expected to see exponential growth in the next few years. It will grow to $18.54 billion in 2029 at a compound annual growth rate (CAGR) of 27.8%. The growth in the forecast period can be attributed to expanded therapeutic applications, regulatory evolution, increased investment, technological innovations, and global collaboration. Major trends in the forecast period include increased demand for personalized therapies, growth in automation and digitalization, expansion of manufacturing capacities, emergence of novel delivery systems, and heightened focus on sustainability and environmental impact.

The increasing prevalence of cancer cases is expected to drive the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market. Cancer, characterized by uncontrolled growth and spread of abnormal cells, is becoming more common due to aging populations, lifestyle changes, environmental exposures, and improved detection methods. CDMOs play a crucial role in combating cancer by developing and manufacturing innovative, targeted treatments that improve efficacy and patient outcomes. For example, according to Macmillan Cancer Support, a UK-based charitable organization, the number of people living with cancer in the UK is projected to rise from 3 million in 2022 to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the increasing prevalence of cancer cases is fueling the growth of the cell and gene therapy CDMO market.

Major companies in the cell and gene therapy contract development and manufacturing organization (CDMO) market are concentrating on broadening their portfolio by integrating advanced solutions such as PluriMatrix technology to improve the scalability, efficiency, and quality of cell-based product manufacturing. PluriMatrix technology is a proprietary system designed for large-scale production of cell-based products. This innovative technology enables 3D expansion of cells on an industrial scale, ensuring high yield and consistent quality through an automated, fully controlled, and validated process. For example, in January 2024, Pluri, a biotech company based in Israel, introduced PluriCDMO, a new business division providing cell therapy manufacturing services as a CDMO. This new division encompasses a 47,000-square-foot good manufacturing practice (GMP) cell therapy production facility. Pluri's newly established division delivers end-to-end services ranging from early preclinical stages to late-stage clinical trials and commercialization, covering process and analytical development, scale-up, validation, logistics, automation, and regulatory-approved comparability studies, as outlined in a company announcement. It harnesses the company's state-of-the-art PluriMatrix technology to provide advanced cell therapy manufacturing services.

In November 2023, Ajinomoto Co. Inc., a Japan-based company specializing in food and biotechnology, purchased Forge Biologics for $620 million. This acquisition enhances Ajinomoto's worldwide expertise in adeno-associated virus (AAV) and plasmid gene therapy manufacturing, strengthening its current contract development and manufacturing services. Forge Biologics, based in the US, is a contract development and manufacturing organization (CDMO) for gene therapy and a clinical-stage therapeutics company.

Major companies operating in the cell and gene therapy contract development and manufacturing organization (CDMO) market are Pfizer Inc, Merck & Co. Inc., Thermo Fisher Scientific Inc, Novartis AG, FUJIFILM Diosynth Biotechnologies, AGC Biologics, Ajinomoto Co Inc, Lonza Group, Catalent Inc, Charles River Laboratories International Inc, Sartorius Stedim Biotech, Samsung Biologics Co Ltd, WuXi Biologics, Recipharm AB, Almac Group Ltd, KBI Biopharma, Rentschler Biopharma, Bio Elpida, Oxford BioMedica Plc, Avid Bioservices Inc, Cell and Gene Therapy Catapult, VGXI Inc, Genezen Laboratories Inc., Pluri Inc., OmniaBio Inc.

North America was the largest region in the cell and gene therapy contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell and gene therapy contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell and gene therapy contract development and manufacturing organization (CDMO) market includes revenues earned by contract development and manufacturing organizations providing services for the development, manufacturing, and testing of cell and gene therapy products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell and gene therapy contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell and gene therapy contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell and gene therapy contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Gene Therapy; Gene-Modified Cell Therapy; Cell Therapy
• 2) By Phase: Phase 1; Phase 2; Phase 3; Phase 4
• 3) By Indication: Oncology; Infectious Diseases; Neurological Disorders; Rare Diseases; Other Indications
• Subsegments:
• 1) By Gene Therapy: Viral Vector-Based Gene Therapy; Non-Viral Gene Therapy; Plasmid DNA-Based Gene Therapy
• 2) By Gene-Modified Cell Therapy: CAR-T Cell Therapy; TCR-T Cell Therapy; NK Cell Therapy
• 3) By Cell Therapy: Stem Cell Therapy; Progenitor Cell Therapy; Immune Cell Therapy
• Companies Mentioned: Pfizer Inc; Merck & Co. Inc.; Thermo Fisher Scientific Inc; Novartis AG; FUJIFILM Diosynth Biotechnologies
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Characteristics

3. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis
• 5.4. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)

6. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Segmentation

• 6.1. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Gene-Modified Cell Therapy
• Cell Therapy
• 6.2. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phase 1
• Phase 2
• Phase 3
• Phase 4
• 6.3. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Infectious Diseases
• Neurological Disorders
• Rare Diseases
• Other Indications
• 6.4. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Vector-Based Gene Therapy
• Non-Viral Gene Therapy
• Plasmid DNA-Based Gene Therapy
• 6.5. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Gene-Modified Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CAR-T Cell Therapy
• TCR-T Cell Therapy
• NK Cell Therapy
• 6.6. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stem Cell Therapy
• Progenitor Cell Therapy
• Immune Cell Therapy

7. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

• 7.1. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 8.1. Asia-Pacific Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 9.1. China Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 9.2. China Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 10.1. India Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 11.1. Japan Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 11.2. Japan Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 12.1. Australia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 13.1. Indonesia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 14.1. South Korea Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 14.2. South Korea Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 15.1. Western Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 15.2. Western Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 16.1. UK Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 17.1. Germany Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 18.1. France Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 19.1. Italy Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 20.1. Spain Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 21.1. Eastern Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 21.2. Eastern Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 22.1. Russia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 23.1. North America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 23.2. North America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 24.1. USA Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 24.2. USA Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 25.1. Canada Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 25.2. Canada Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 26.1. South America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 26.2. South America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 27.1. Brazil Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 28.1. Middle East Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 28.2. Middle East Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

• 29.1. Africa Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Overview
• 29.2. Africa Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

• 30.1. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape
• 30.2. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. FUJIFILM Diosynth Biotechnologies Overview, Products and Services, Strategy and Financial Analysis

31. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

• 31.1. AGC Biologics
• 31.2. Ajinomoto Co Inc.
• 31.3. Lonza Group
• 31.4. Catalent Inc.
• 31.5. Charles River Laboratories International Inc.
• 31.6. Sartorius Stedim Biotech
• 31.7. Samsung Biologics Co Ltd
• 31.8. WuXi Biologics
• 31.9. Recipharm AB
• 31.10. Almac Group Ltd
• 31.11. KBI Biopharma
• 31.12. Rentschler Biopharma
• 31.13. Bio Elpida
• 31.14. Oxford BioMedica Plc
• 31.15. Avid Bioservices Inc.

32. Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

34. Recent Developments In The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market

35. Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

• 35.1 Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료